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Introduction. Pseudomonas aeruginosa is a Gram-negative nosocomial pathogen, often causative agent of severe devise-related infections, given its great ability to form biofilm. Pseudomonas
regulates the expression of numerous virulence factors, including biofilm production, by Quorum Sensing (QS), a cell-to-cell communication mechanism used by many bacteria. Inhibition of QS-
controlled pathogenicity without affecting the P. aeruginosa growth, may thus represent a promising strategy to overcome its widespread and constantly increasing drug-resistance.
Aim. We investigated the effects of SM23, a boronic acid derivative, specifically designed as beta-lactamase inhibitor, on biofilm formation and virulence factors production by P. aeruginosa.
Methods. The P. aeruginosa bioluminescent strain P1242 was used employing bioluminescence, colorimetric and fluorescence assays (microbial growth, biofilm, elastase) as well as mass
spectrometry (pyocyanin, pyoverdine and quorum sensing molecules)
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Results: 1. Inhibitory Effects of SM23 on P. aeruginosa
Biofilm Formation
SM23 is a boronic acids transition state analog inhibitor
(BATSI) of β-lactamases from class C (PDC-3) and class A
(CTXM-16)
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black-plates, containing 1 endotracheal tube (ETT) piece/well; the 
plates were then incubated for 90 min at 37°C (adhesion period). 
After incubation, the ETT pieces were washed twice with PBS, 
transferred into new wells, and incubated for further 24  h at 
37°C in fresh TSB medium in the presence of SM23 (1.560 and 
3.150 μM) to allow biofilm formation. At the end of incubation, 
the ETT pieces were removed, washed twice with PBS, and the 
bioluminescence signal was measured by Viktor Luminescence 
reader (Perkin Elmer). The values were expressed as Relative 
Luminescence Units (RLU). In parallel, after removing ETT pieces, 
the supernatants were recovered and centrifuged twice (10,000 rpm 
for 15 min) to remove the remaining bacteria. Pyoverdine release 
was quantified in 100 μl of culture supernatants and fluoresce ce 
emission was measured with a multi-well fluorescence plate reader 
(excitation/emission: 360/460), according to a standard protocol 
(Das et  al., 2016). The values were expressed as RFU.
Statistical Analysis
Quantitative variables were tested for normal distribution. 
Statistical differences between groups were analyzed according 
to one-way ANOVA or Kruskal-Wallis followed by Dunnett’s 
multiple comparisons tests by using GraphPad prism 8. A 
value of p  ≤   0.05 was considered significant.
RESULTS
Inhibitory Effects of SM23 on 
Pseudomonas aeruginosa Biofilm 
Formation
Dose-dependent experiments were performed to assess the 
ability of SM23 to interfere with the biofilm formation by P. 
aeruginosa. Microbial cells were grown in a 96-well microtiter 
plate in medium only or in the presence of scalar doses of 
SM23 and then incubated for 24 h to allow biofilm formation. 
After incubation, each well was gently washed to remove 
planktonic cells and then CV staining was performed to quantify 
the biofilm biomass. The results shown in Figure 2 (left panel) 
indicated that the SM23, at the dose of 0.390 μM, was already 
able to significantly inhibit biofilm formation (about 40% of 
biofilm biomass), achieving its greatest effect in the dose range 
of 0.780–6.250 μM (about 50% of biomass reduction observed). 
Next, we  analyzed the inhibitory effect of SM23 on biofilm, 
exploiting the bioluminescent properties of P. aeruginosa strain 
P1242, a model that allows to evaluate the effects of a given 
compound directly on the metabolically active biofilm (Pericolini 
et  al., 2018). Thus, bacterial biofilm was allowed to form in 
96-black well microtiter plat s without or with SM23 at different 
concentrations. After 24 h of incubation, each well was gently 
washed to remove plankto ic cells and, then, the RLU emitted 
by the metabolically active bacteria embedded in biofilm were 
measured. Results in Figure  2 (right panel) indicated that 
SM23 significantly reduced biofilm formation in a dose-dependent 
manner (from 0.390 to 25  μM concentration). In particular, 
1.560 and 3.125  μM were the lowest SM23 doses still capable 
of reducing biofilm by 50–60%. Thus, from now on, we mainly 
used these two concentrations.
In parallel experiments, the influence of SM23 was evaluated 
on the growth of P. aeruginosa, cultured in planktonic form 
for 7 and 24  h. We  found that SM23 failed to induce any 
change on bacterial growth capacity and viability as well, up 
to the concentration of 25.0  μM; also, the bacterial doubling 
times were found to be  comparable, in SM23-treated and 
untreated controls (data not shown).
Morphological Observation of  
SM23-Treated Biofilm
We next performed confocal analysis in a 24  h-old biofilm, 
produced in medium alone or in the presence of SM23, at 
0.780 and 3.125  μM. As expected, both doses strongly affected 
biofilm development and its morphology. Indeed, as shown in 
Figure  3 (left panel), unlike controls, SM23-treated biofilms 
showed large zones with few or no bacteria and scant extracellular 
matrix onto the well surface. Moreover, the residual biofilm 
FIGURE 2 | Dose-dependent effect of SM23 on P. aeruginosa biofilm formation. Both box-plot graphs show the mean ± SEM of microbial biofilm produced 
after 24 h of incubation in medium or in the presence of scalar doses of SM23. Left panel: mean ± SEM of the OD570nm (biofilm biomass) of triplicate samples from 
two different experiments. Right panel: mean ± SEM of the Relative Luminescence Units (RLU) of triplicate samples from two different experiments. p < 0.05;  
SM23-treated vs. untreated according to one-way ANOVA followed by Dunnett’s multiple comparisons test.Dose-dependent effect of SM23 on P. aeruginosa
biofilm formation. Both box-plot graphs show the mean ±
SEM of microbial biofilm produced after 24 h of incubation
in medium or in the presence of scalar doses of SM23. Left
panel: OD570nm (biofilm biomass). Right panel: Relative
Luminescence Units (RLU).
2. Inhibition of P. aeruginosa Quorum Sensing-
Related Virulence Factors by SM23
Py= Pyoverdine
3-oxoC12-HSL= N-(3-Oxododecanoyl)-L-homoserine lactone
C4-HSL= N-(butanoyl)-homoserine lactone
3. Inhibition of P. aeruginosa Quorum Sensing Molecules by SM23
4. SM23 Interaction With P. aeruginosa 5. SM23 Inhibitory Effects on Endotracheal
Tubes-Associated Biofilm
SM23 interaction with P. aeruginosa.
Mean percent ± SEM of the
fluorescence signal detected both in the
cell-free supernatant (sup) and in the
pellet as specified in the experimental
time-line (see above).
SM23 effects on medical devise-associated
biofilm by P. aeruginosa: impairment of
pyoverdine release and biofilm formation.
Biofilm mass (upper panel), expressed as
mean RLU ± SEM, and pyoverdine release
(lower panel), expressed as mean RFU ±
SEM, by a 24 h-old Pseudomonas biofilm
produced on ETT pieces, in the absence and
in the presence of SM23.Conclusions. Our results indicate that, besides inhibiting β-lactamase, SM23 can also act as powerful inhibitor of P. aeruginosa biofilm,
suggesting that it may have a potential application in the prevention and treatment of biofilm-associated P. aeruginosa infections.
Full details of the present work have been published in Front. Microbiol. 11:35. doi: 10.3389/fmicb.2020.00035
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